Early rhythm‐control ablation therapy to prevent atrial fibrillation recurrences: Insights from the CHARISMA Registry-Reference-Cited by-同舟云学术

Early rhythm‐control ablation therapy to prevent atrial fibrillation recurrences: Insights from the CHARISMA Registry

Published:2021-10-21 Issue:12 Volume:44 Page:2031-2040
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing Clinical Electrophis

Author:

Solimene Francesco¹,Giannotti Santoro Mario²^ORCID,Stabile Giuseppe¹³^ORCID,Malacrida Maurizio⁴^ORCID,De Simone Antonio⁵,Pandozi Claudio⁶,Pelargonio Gemma⁷⁸,Rossi Pietro⁹,Battaglia Alberto¹⁰,Pecora Domenico¹¹,Bongiorni Maria Grazia²,Zucchelli Giulio²,Stocco Camilla⁴,Arestia Alberto¹,Iuliano Sara⁵,Russo Maurizio⁶,Narducci Maria Lucia⁷,Segreti Luca²

Affiliation:

1. Clinica Montevergine Mercogliano Avellino Italy

2. Second Division of Cardiology Cardiac Thoracic Vascular Department New Santa Chiara Hospital Azienda Ospedaliero Universitaria Pisana Pisa Italy

3. Anthea Hospital Bari Italy

4. Boston Scientific Milan Italy

5. Laboratorio di Elettrofisiologia Clinica San Michele Maddaloni Caserta Italy

6. Division of Cardiology San Filippo Neri Hospital Rome Italy

7. Department of Cardiovascular Sciences Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

8. Institute of Cardiology Catholic University of Sacred Heart Rome Italy

9. Arrhythmology Unit Ospedale San Giovanni Calibita Fatebefratelli Isola Tiberina Rome Italy

10. Cardinal Massaia Hospital Asti Italy

11. Electrophysiology Unit Cardiovascular Department Poliambulanza Institute Hospital Foundation Brescia Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pace.14374

Reference27 articles.

1. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation

2. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

3. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis

4. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation

5. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity‐Score Matching Study and Meta‐Analysis;Journal of the American Heart Association;2023-12-19

2. Timing of cryoballoon pulmonary vein isolation to prevent atrial fibrillation recurrence;Journal of Interventional Cardiac Electrophysiology;2023-09-11

3. The Impact of COVID-19 Pandemic on the Clinical Practice Patterns in Atrial Fibrillation: A Multicenter Clinician Survey in China;Journal of Clinical Medicine;2022-10-31

4. Improved procedural workflow for catheter ablation of paroxysmal AF with high‐density mapping system and advanced technology: Rationale and study design of a multicenter international study;Clinical Cardiology;2022-04-21